| UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00042861) | National Cancer Institute (NCI) | 2002-08-01 |
| E7389 in Treating Patients With Advanced Solid Tumors (NCT00047034) | National Cancer Institute (NCI) | 2002-08-01 |
| Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors (NCT00390429) | University of California, Davis | 2002-07-01 |
| Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00046917) | National Cancer Institute (NCI) | 2002-07-01 |
| BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors (NCT00043095) | Memorial Sloan Kettering Cancer Center | 2002-06-01 |
| Evaluating Patient Participation in Phase I Clinical Trials (NCT00043030) | National Institutes of Health Clinical Center (CC) | 2002-06-01 |
| Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer (NCT00401180) | The Cleveland Clinic | 2002-06-01 |
| UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma (NCT00045500) | National Cancer Institute (NCI) | 2002-06-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery (NCT00043121) | National Cancer Institute (NCI) | 2002-06-01 |
| Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00042874) | National Cancer Institute (NCI) | 2002-05-01 |
| Melatonin and Radiation Therapy in Treating Patients With Brain Metastases (NCT00031967) | Radiation Therapy Oncology Group | 2002-05-01 |
| Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT00042809) | National Cancer Institute (NCI) | 2002-05-01 |
| Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00084734) | Roswell Park Cancer Institute | 2002-05-01 |
| Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care (NCT00045019) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-05-01 |
| Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer (NCT00062231) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-04-01 |
| Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors (NCT00039390) | National Cancer Institute (NCI) | 2002-04-01 |
| Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00045448) | Memorial Sloan Kettering Cancer Center | 2002-04-01 |
| CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy (NCT00031941) | National Institutes of Health Clinical Center (CC) | 2002-04-01 |
| Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis (NCT00033605) | Alliance for Clinical Trials in Oncology | 2002-04-01 |
| Carmustine Implants in Treating Patients With Brain Metastases (NCT00003878) | New Approaches to Brain Tumor Therapy Consortium | 2002-04-01 |
| Pyroxamide in Treating Patients With Advanced Cancer (NCT00042900) | Memorial Sloan Kettering Cancer Center | 2002-04-01 |
| Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C (NCT00040729) | National Cancer Institute (NCI) | 2002-03-01 |
| Improving Pain Management in Patients With Nonhematologic Cancer (NCT00036829) | Inflexxion, Inc. | 2002-03-01 |
| UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors (NCT00036777) | National Cancer Institute (NCI) | 2002-03-01 |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors (NCT00052403) | Barbara Ann Karmanos Cancer Institute | 2002-02-01 |
| Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer (NCT00036790) | University of Wisconsin, Madison | 2002-02-01 |
| KRN5500 in Treating Patients With Solid Tumors (NCT00017238) | National Cancer Institute (NCI) | 2002-02-01 |
| XK469 in Treating Patients With Advanced Solid Tumors (NCT00028548) | Barbara Ann Karmanos Cancer Institute | 2002-01-01 |
| 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors (NCT00028821) | National Cancer Institute (NCI) | 2002-01-01 |
| Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00027898) | National Cancer Institute (NCI) | 2002-01-01 |
| PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00028587) | National Cancer Institute (NCI) | 2001-12-01 |
| Etoposide and Celecoxib in Patients With Advanced Cancer (NCT00551005) | City of Hope Medical Center | 2001-12-01 |
| Vaccine Therapy in Treating Patients With Metastatic Solid Tumors (NCT00030693) | National Cancer Institute (NCI) | 2001-12-01 |
| Decitabine in Treating Patients With Advanced Solid Tumors (NCT00030615) | National Cancer Institute (NCI) | 2001-12-01 |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681) | National Cancer Institute (NCI) | 2001-12-01 |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498) | National Cancer Institute (NCI) | 2001-12-01 |
| Radiofrequency Ablation in Treating Patients With Bone Metastases (NCT00026247) | American College of Radiology Imaging Network | 2001-11-01 |
| Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00030368) | National Cancer Institute (NCI) | 2001-11-01 |
| VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma (NCT00036946) | Regeneron Pharmaceuticals | 2001-11-01 |
| BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors (NCT00028561) | National Cancer Institute (NCI) | 2001-10-01 |
| S-3304 in Treating Patients With Advanced Solid Tumors (NCT00033566) | Roswell Park Cancer Institute | 2001-10-01 |
| Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia (NCT00020865) | Jonsson Comprehensive Cancer Center | 2001-09-01 |
| Irinotecan in Treating Aging Patients With Solid Tumors (NCT00026195) | Alliance for Clinical Trials in Oncology | 2001-09-01 |
| Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer (NCT00551889) | City of Hope Medical Center | 2001-09-01 |
| Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00024310) | Jonsson Comprehensive Cancer Center | 2001-09-01 |
| Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure (NCT00026169) | National Cancer Institute (NCI) | 2001-09-01 |
| 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors (NCT00030095) | National Cancer Institute (NCI) | 2001-09-01 |
| Phenoxodiol in Treating Patients With Refractory Solid Tumors (NCT00022295) | Kazia Therapeutics Limited | 2001-08-01 |
| Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors (NCT00027677) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-08-01 |
| R115777 in Treating Patients With Advanced Solid Tumors (NCT00025454) | City of Hope Medical Center | 2001-08-01 |
| Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma (NCT00027937) | Fred Hutchinson Cancer Center | 2001-08-01 |
| Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction (NCT00025415) | National Cancer Institute (NCI) | 2001-08-01 |
| Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors (NCT00054288) | Roswell Park Cancer Institute | 2001-08-01 |
| Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors (NCT00033241) | OSI Pharmaceuticals | 2001-07-23 |
| Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor (NCT00021047) | National Institutes of Health Clinical Center (CC) | 2001-07-01 |
| Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment (NCT00608738) | Northwestern University | 2001-07-01 |
| SU6668 in Treating Patients With Advanced Solid Tumors (NCT00024206) | National Cancer Institute (NCI) | 2001-07-01 |
| BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors (NCT00022529) | National Cancer Institute (NCI) | 2001-07-01 |
| Personalized Nutrition Education in Improving Eating Habits of Healthy Participants Who Eat an Unhealthy Diet (NCT00301678) | Brown University | 2001-06-01 |
| PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors (NCT00023855) | University of Wisconsin, Madison | 2001-06-01 |
| Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors (NCT00024141) | Roswell Park Cancer Institute | 2001-05-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00021073) | National Cancer Institute (NCI) | 2001-05-01 |
| EMD 121974 in Treating Patients With Advanced Solid Tumors (NCT00022113) | National Cancer Institute (NCI) | 2001-05-01 |
| Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer (NCT00237627) | UNC Lineberger Comprehensive Cancer Center | 2001-05-01 |
| Vaccine Therapy in Treating Patients With Metastatic Cancer (NCT00021164) | National Cancer Institute (NCI) | 2001-05-01 |
| 10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid Tumors (NCT00024245) | Memorial Sloan Kettering Cancer Center | 2001-05-01 |
| Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors (NCT00016185) | Barbara Ann Karmanos Cancer Institute | 2001-03-01 |
| UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors (NCT00006464) | City of Hope Medical Center | 2001-03-01 |
| Benzoylphenylurea in Treating Patients With Advanced Solid Tumors (NCT00016354) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2001-03-01 |
| 7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors (NCT00012194) | National Cancer Institute (NCI) | 2001-03-01 |
| Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain (NCT00020618) | Dana-Farber Cancer Institute | 2001-03-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00024323) | Vion Pharmaceuticals | 2001-03-01 |
| VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas (NCT00025129) | Vion Pharmaceuticals | 2001-03-01 |
| Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors (NCT00020488) | National Cancer Institute (NCI) | 2001-02-01 |
| Valdecoxib in Treating Chronic Pain in Cancer Patients (NCT00021996) | Dana-Farber Cancer Institute | 2001-01-01 |
| CCI-779 in Treating Patients With Advanced Solid Tumors (NCT00003712) | The University of Texas Health Science Center at San Antonio | 2001-01-01 |
| Combination Chemotherapy in Treating Patients With Solid Tumors (NCT00009932) | Ohio State University Comprehensive Cancer Center | 2001-01-01 |
| Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00006465) | Case Comprehensive Cancer Center | 2000-12-01 |
| Benzoylphenylurea in Treating Patients With Advanced Cancer (NCT00010205) | National Cancer Institute (NCI) | 2000-12-01 |
| ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00016172) | Memorial Sloan Kettering Cancer Center | 2000-11-01 |
| SU5416 and Paclitaxel in Treating Patients With Advanced Cancer (NCT00006257) | City of Hope Medical Center | 2000-11-01 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer (NCT00009958) | National Cancer Institute (NCI) | 2000-11-01 |
| BMS-247550 in Treating Patients With Advanced Cancers (NCT00006221) | National Cancer Institute (NCI) | 2000-11-01 |
| Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment (NCT00006348) | Alliance for Clinical Trials in Oncology | 2000-10-01 |
| Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors (NCT00014378) | Memorial Sloan Kettering Cancer Center | 2000-10-01 |
| Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors (NCT00014248) | Dartmouth-Hitchcock Medical Center | 2000-10-01 |
| Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors (NCT00014261) | Dartmouth-Hitchcock Medical Center | 2000-10-01 |
| Effects of Fetal, Infant, and Early Childhood Exposures on Adult Cancer Risk in Women (NCT00559039) | National Institutes of Health Clinical Center (CC) | 2000-10-01 |
| Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors (NCT00006477) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-09-01 |
| Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery (NCT00007878) | National Cancer Institute (NCI) | 2000-09-01 |
| BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy (NCT00020371) | National Cancer Institute (NCI) | 2000-09-01 |
| Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors (NCT00006485) | Memorial Sloan Kettering Cancer Center | 2000-09-01 |
| Nutrition Education for Low-Income Healthy Participants Who Eat an Unhealthy Diet (NCT00301691) | Brown University | 2000-09-01 |
| SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00006000) | Ohio State University Comprehensive Cancer Center | 2000-08-01 |
| Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor (NCT00005839) | City of Hope Medical Center | 2000-08-01 |
| Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy (NCT00005994) | University of Rochester | 2000-08-01 |
| Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer (NCT00020748) | Georgetown University | 2000-08-01 |
| R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors (NCT00005990) | NYU Langone Health | 2000-08-01 |
| Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy (NCT00006354) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-08-01 |
| BMS-214662 in Treating Patients With Advanced Solid Tumors (NCT00006242) | National Cancer Institute (NCI) | 2000-07-01 |